This webinar will unravel the challenges in quantifying medical science liaisons’ value, explore how they are enhancing impact through strategic engagement, unpack new ways of measuring value beyond output and illustrate how companies can further empower medical science liaisons with data-driven artificial intelligence (AI)/tech-enabled solutions.
While the medical science liaison role is expanding across all stages of pharmaceutical development and to encompass a growing number of audiences, the industry is struggling to measure the impact of medical science liaison activities. However, the race is on to develop the right key performance indicators, training, measurement tools and processes for gauging the impact of medical science liaison teams and ultimately improving outcomes.
Medical science liaisons within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering. Only they can share certain types of information with a growing number of medical stakeholders and provide medical insights to guide strategic development and brand decisions.
In this webinar, the attendees will learn about how medical science liaisons can strategically engage with a variety of stakeholders to gather critical insights that shape medical strategies and influence development decisions; discover how customized solutions, such as AI-driven sentiment analysis and insights reporting, can enhance medical science liaisons’ capabilities; and explore innovative methods for assessing the impact of medical science liaisons’ activities.
Do not miss this opportunity to gain actionable strategies for maximizing the value of medical science liaisons and driving better outcomes in pharmaceutical development.
Speakers
Angela Wlodar, MS, Senior Vice President, Medical Affairs Business Development, Syneos Health
Angela Wlodar has been at Syneos Health for over three years, supporting the business development initiatives and team for Integrated Medical Affairs and end-to-end Patient Support Services.
Prior to joining Syneos Health, Angela spent 15 years at Abbott (formerly St. Jude Medical) where she was the Director of Global Field Clinical Affairs. In this role, she managed a team of 17 International Field Clinical Engineers responsible for all aspects of clinical trial execution for the Neuromodulation Business Unit.
Read more...
She has extensive experience in medical device and diagnostics with an emphasis in cardiovascular and CNS therapeutic areas. Angela holds a Master’s degree from Ohio University.
Read Less...
Mike DeGeorge, PharmD, BCMAS, Vice President, Medical Affairs, Deployment Solutions, Syneos Health
Mike DeGeorge is currently a Vice President, Medical Affairs at Syneos Health, supporting the deployment of field medical teams in North America. Prior to that, Mike was the Vice President of Medical Affairs for Collegium Pharmaceutical, where he built and led Collegium’s first Medical Affairs team.
Mike has 19 years of industry experience dedicated to Medical Affairs. Prior to joining Collegium, he was the Director of Medical Affairs for Ameritox, where he a led a team of field-based scientists and oversaw the research and publication strategy. Prior to Ameritox, he held Field Medical Affairs positions of increasing responsibility in the pharmaceutical industry, including positions at King Pharmaceuticals, Archimedes and Sanofi-Aventis.
He earned a Bachelor’s degree in Pharmacy from St. John’s University in New York and a Doctor of Pharmacy Degree from the University of Florida.
Mayank Pandita, Director, Strategic Business Analytics, Deployment Solutions, Syneos Health
Mayank Pandita is a seasoned professional in the Life Sciences industry with a focus on Strategy, Operations and the evolving field of Business Insights and Artificial Intelligence. Mayank has ~9 years of experience in Life Sciences spanning across clients from various continents. He has displayed a proven track record in steering Commercial and Medical Affairs strategies with acuity and foresight.
Mayank brings an exceptional fusion of strategic consulting prowess and technology/data science ingenuity. He is adept at navigating and orchestrating analytics and technology initiatives. Known for his analytical sharpness and expertise, he addresses complex challenges, equips organizations with the tools to decode and leverage their metrics and unlocks avenues for growth and forward-thinking actions.
Read more...
Before his tenure at Syneos Health, Mayank worked with ZS Associates as a Consultant and boasts a solid foundation with a Bachelor’s degree in Computer Science and Engineering.
Read Less...
Celeste Mosby, Senior Vice President and General Manager, Learning Solutions, Syneos Health
Celeste Mosby brings more than 20 years of industry and partner experience to the learning solutions capability at Syneos Health. A recognized leader in the industry, Celeste and her team partner with major pharmaceutical, biotech and healthcare organizations in developing targeted medical and commercial state-of-the-art digital and live educational programs, earning her clients significant impact on patient outcomes.
Celeste also serves as a strategic consultant to senior executives in medical, sales and commercial marketing to determine disease state education and product positioning needs across many therapeutic areas, including oncology, diabetes, CV, CHF, rare disease and diagnostics. In her position, Celeste links physician and consumer behavioral data to strategic and innovative learning/training and commercial launch/brand sustainment solutions.
Read more...
Celeste also worked in sales for Eli Lilly, as an antiviral marketing specialist for Astra Pharmaceuticals in the hospital division and as a clinical liaison manager at Managed Healthcare Associates, where she developed customized formularies, education and pull-through programs for physicians, nurses, consultant pharmacists and other healthcare professionals.
Celeste holds a BS degree from Seton Hall University’s Stillman School of Business with a concentration in marketing.
Read Less...
Who Should Attend?
This webinar will appeal to executives involved in medical affairs, medical field teams, training and real-world evidence.
What You Will Learn
In this webinar, attendees will:
- UNDERSTAND how MSLs can strategically engage with diverse stakeholders to gather valuable insights that inform medical strategy and drive development decisions
- DISCOVER how customized solutions, including AI-driven sentiment analysis and insights reporting, can amplify MSL capabilities
- EXPLORE innovative approaches to measuring the impact of MSL activities beyond mere task completion to the use of training and technology to empower the agility needed to support patient-powered medicine
Xtalks Partner
Syneos Health®
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. They translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Together they share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. They support a diverse, equitable and inclusive culture.
To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account